ARCH Venture Partners IX Overage, L.P. — Vir Biotechnology, Inc. insider: 18 transactions · InsiderLens

ARCH Venture Partners IX Overage, L.P. — Vir Biotechnology, Inc. insider: 18 transactions · InsiderLens

Empresa	Notificado	Tipo	Cant.	Precio	Valor · USD	Fuente	Detalle
Lyell Immunopharma, Inc.	Mar 9, 2026	Compra	488,090	25.61 USD	$12.5M	SEC
Vir Biotechnology, Inc.	Jun 10, 2022	Otro	1,475	0.00 USD	—	SEC
Vir Biotechnology, Inc.	Jun 10, 2022	Otro	13,076	0.00 USD	—	SEC
Vir Biotechnology, Inc.	Jun 10, 2022	Otro	-217,781	0.00 USD	—	SEC
Vir Biotechnology, Inc.	Jun 10, 2022	Otro	2,952	0.00 USD	—	SEC
Vir Biotechnology, Inc.	Jun 10, 2022	Otro	-282,219	0.00 USD	—	SEC
Karuna Therapeutics, Inc.	Apr 15, 2021	Otro	-75,000	0.00 USD	—	SEC
Karuna Therapeutics, Inc.	Apr 15, 2021	Otro	958	0.00 USD	—	SEC
Karuna Therapeutics, Inc.	Apr 15, 2021	Otro	306	0.00 USD	—	SEC
Karuna Therapeutics, Inc.	Apr 15, 2021	Otro	-75,000	0.00 USD	—	SEC
Vir Biotechnology, Inc.	Apr 9, 2021	Otro	1,019	0.00 USD	—	SEC
Vir Biotechnology, Inc.	Apr 9, 2021	Otro	3,161	0.00 USD	—	SEC
Vir Biotechnology, Inc.	Apr 9, 2021	Otro	3,161	0.00 USD	—	SEC
Vir Biotechnology, Inc.	Apr 9, 2021	Otro	-282,219	0.00 USD	—	SEC
Vir Biotechnology, Inc.	Apr 9, 2021	Otro	1,019	0.00 USD	—	SEC
Vir Biotechnology, Inc.	Apr 9, 2021	Otro	-217,781	0.00 USD	—	SEC
Vir Biotechnology, Inc.	Apr 9, 2021	Otro	-282,219	0.00 USD	—	SEC
Vir Biotechnology, Inc.	Apr 9, 2021	Otro	-217,781	0.00 USD	—	SEC